PRF Technologies Ltd. (PRFX) SEC filings

PRFXNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 26, 2026Score 6/30

$0.79+0.04 (+5.82%)

Close on Nov 12, 2026Market cap $653.53KP/E –Yield –

SEC filings

40 of PRF Technologies's most recent filings on SEC EDGAR

Document	Form	Period	Filed	Source
Current report	6-K	Nov 12, 2026	Nov 12, 2026	SEC EDGAR
Current report	6-K	Nov 5, 2026	Nov 5, 2026	SEC EDGAR
Current report	6-K	Nov 3, 2026	Nov 3, 2026	SEC EDGAR
Current report	6-K	Oct 23, 2026	Oct 23, 2026	SEC EDGAR
Current report	6-K	Sep 28, 2026	Sep 28, 2026	SEC EDGAR
Current report	6-K	Sep 16, 2026	Sep 16, 2026	SEC EDGAR
Current report	6-K	Sep 9, 2026	Sep 9, 2026	SEC EDGAR
Current report	6-K	Jun 30, 2026	Sep 3, 2026	SEC EDGAR
Current report	6-K	Jul 27, 2026	Jul 27, 2026	SEC EDGAR
Current report	6-K	Jul 21, 2026	Jul 21, 2026	SEC EDGAR
Current report	6-K	Jul 15, 2026	Jul 15, 2026	SEC EDGAR
Current report	6-K	Jul 8, 2026	Jul 8, 2026	SEC EDGAR
Current report	6-K	Jun 25, 2026	Jun 25, 2026	SEC EDGAR
Current report	6-K	Jun 18, 2026	Jun 18, 2026	SEC EDGAR
Current report	6-K	May 28, 2026	May 28, 2026	SEC EDGAR
Current report	6-K	May 26, 2026	May 26, 2026	SEC EDGAR
Current report	6-K	May 7, 2026	May 7, 2026	SEC EDGAR
Current report	6-K	Apr 28, 2026	Apr 28, 2026	SEC EDGAR
Current report	6-K	Mar 27, 2026	Mar 27, 2026	SEC EDGAR
Annual report	20-F	Dec 31, 2025	Mar 26, 2026	SEC EDGAR
Current report	6-K	Mar 17, 2026	Mar 17, 2026	SEC EDGAR
Current report	6-K	Mar 3, 2026	Mar 3, 2026	SEC EDGAR
Current report	6-K	Feb 18, 2026	Feb 18, 2026	SEC EDGAR
Current report	6-K	Feb 11, 2026	Feb 11, 2026	SEC EDGAR
Current report	6-K	Feb 2, 2026	Feb 3, 2026	SEC EDGAR
Current report	6-K	Jan 20, 2026	Jan 20, 2026	SEC EDGAR
Current report	6-K	Jan 15, 2026	Jan 15, 2026	SEC EDGAR
Current report	6-K	Jan 12, 2026	Jan 12, 2026	SEC EDGAR
Current report	6-K	Jan 7, 2026	Jan 7, 2026	SEC EDGAR
Current report	6-K	Jan 6, 2026	Jan 6, 2026	SEC EDGAR
Current report	6-K	Jan 5, 2026	Jan 5, 2026	SEC EDGAR
Current report	6-K	Dec 30, 2025	Dec 30, 2025	SEC EDGAR
Current report	6-K	Dec 10, 2025	Dec 10, 2025	SEC EDGAR
Current report	6-K	Dec 2, 2025	Dec 2, 2025	SEC EDGAR
Current report	6-K	Nov 25, 2025	Nov 25, 2025	SEC EDGAR
Current report	6-K	Nov 12, 2025	Nov 12, 2025	SEC EDGAR
Current report	6-K	Nov 5, 2025	Nov 5, 2025	SEC EDGAR
Current report	6-K	Jun 30, 2025	Oct 1, 2025	SEC EDGAR
Current report	6-K	Aug 19, 2025	Aug 19, 2025	SEC EDGAR
Current report	6-K	Aug 13, 2025	Aug 13, 2025	SEC EDGAR

Where these numbers come from

Parsed from the XBRL in PRF Technologies's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-5 reverse split on Feb 6, 2026
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is PRFX.

Compare: PRFX vs KPRX · PRFX vs JUNS · PRFX vs KZIA · PRFX vs ADXN · PRFX vs CNBX

Company	Revenue	Growth
PRFX	$17.00K	–
KPRX	–	–
JUNS	–	–
KZIA	–	–
ADXN	–	–
CNBX	$0	–

Company

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
Fiscal year ends: December 31
Employees: 6
Held by institutions: 24.5%
Auditor: Kesselman & Kesselman
SEC CIK: 1801834

Advertisement
300 × 250

See a number that looks wrong?